Skin moles that cause hair to grow may offer baldness treatment, study suggests

Skin moles that cause hair to grow may offer baldness treatment, study suggests

Unsightly skin moles may offer a potential avenue for treating hair loss, according to a study published this week in the journal Nature.

For nearly a decade, scientists at the University of California at Irvine have been studying skin moles to understand why they produce such long hairs. Their new paper shows that such moles contain particular molecules that promote hair growth.

“Nature gave us clues in those hairy-skinned moles,” said Maksim Plikus, the study’s lead author and a professor of cell and developmental biology at UC Irvine.

A mole with three hairs growing in the middle.
A mole with three hairs growing in the middle.Ilookeye/Getty Images

People typically lose between 50 and 100 hairs per day and then grow new hair from stem cells in hair follicles. But in people with baldness or pattern baldness, what doctors call alopecia or androgenic alopecia, the stem cells lie dormant, so new hair cannot grow.

In experiments with mice, Plikus and his research team showed that a molecule called osteopontin, which is especially prominent in hairy skin moles, could activate previously dormant hair follicle stem cells.

The researchers tested this by grafting human skin samples onto mice and then giving the animals three injections of the molecule, spaced one day apart. Within days, the injections helped the mice grow new hairs about 1 centimeter long.

To verify that osteopontin was responsible for hair growth, the researchers also injected a neutral protein into a different site on the skin, but no new hair grew at that injection site.

Plikus said that unlike studies that focus on mouse fur, his findings are more applicable to humans because the experiment used human skin samples and tested for a molecule found in human moles.

“The mechanism they identified in mice appeared to be applicable to understanding hair follicle growth in humans. That’s a remarkable part of the study,” said Mayumi Ito, a professor of dermatology and cell biology at NYU Langone Health, who was not involved in the study. investigation.

Plikus hopes his research could eventually lead to an outpatient procedure to promote hair growth, perhaps performed in a dermatologist’s office, similar to a cosmetic procedure like Botox. The molecule would take the form of a gel and be injected or delivered through a process called microneedling, which rolls tiny needles over the skin, he said.

In theory, Plikus said, people could see their natural hair grow as they did before they experienced baldness.

“Your pre-existing dormant hair follicles will wake up and start growing again,” Plikus said. “Once they start to grow, they will naturally produce hair with qualities you remember when you were 18 years old. It will be the same thickness and length. It will be straight or curly.”

Plikus is the co-founder of Amplifica, a biotech company that licenses his research and puts it into clinical trials. Started in 2019, the company hopes to begin its first human trial in the coming months to test the safety of a compound designed to deliver osteopontin to the body. The compound will be delivered via scalp injections, according to Frank Fazio, Amplifica’s CEO.

The company also plans to conduct a subsequent trial to assess the safety of a synthetic version of osteopontin.

“We will certainly study both men and women throughout our clinical program,” Fazio said.

‘We have treatments, but we don’t have solutions’

The Food and Drug Administration has approved two hair loss treatments: the drugs commonly sold under the brand names Propecia and Rogaine. Propecia is a prescription pill, while Rogaine is a liquid or foam that is applied directly to the skin.

Both were approved decades ago, although Propecia is not approved for use in women. And both have side effects: Rogaine can cause skin irritation or unwanted facial hair, and Propecia can lead to erectile dysfunction or reduced sex drive.

None of the drugs is completely effective in restoring hair loss.

“We have treatments, but we don’t have solutions,” said Dr. Jeremy Green, a board-certified dermatologist in Miami and a consultant to Amplifica.

In his practice, Green said, he commonly sees women in their 30s and 40s whose hair is thinning and men in their teens or early 20s with receding hairlines.

“It’s going to be college kids coming in saying, ‘Oh, God, what’s going on? I don’t want to look like my dad,'” he said.

Green said he often prescribes topical treatments like Rogaine first, and then, based on results or patient preference, transitions to Propecia or its generic forms. From there, she said, the options become more invasive and include hair transplants or a method called platelet-rich plasma therapy, which injects blood cells into the scalp.

Hair transplants are very effective, Green said, but they can be expensive and require a full-day procedure.

“I wouldn’t say it’s a piece of cake for everyone, and that’s why you still see people with alopecia,” he said.

The molecular injection that Amplifica is developing, Green noted, might not work for hair loss caused by medical conditions such as thyroid disorders. Still, he is hopeful that the injection could benefit many patients with baldness or thinning hair.

“Patients are willing to fly halfway around the planet to get hair transplants and do other things, so the demand is certainly high,” he said.

By Mitchell G. Patton

You May Also Like